GovChime
AWARDDEFINITIVE CONTRACTSmall business

Definitive contract 75N93020C00052HDT BIO CORP

Overview

Award facts

Net obligations
$10.97M
$10,970,058of $10.97M potential value
Outlays (paid to date)
$10.66M
$10.66M paid of $10.97M obligated$10,658,331
Period of performance
Sep 1, 2020 to Jun 30, 2024
Ended
Modifications
5
Latest action Oct 26, 2023
Contract type
Definitive contract
PIID 75N93020C00052

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

COVID-19. TO DEVELOP AND PROGRESS HDT-301, A REPLICON RNA ENCODING SARS-COV-2 SPIKE PROTEIN BOUND TO LIPID INORGANIC NANOPARTICLE (LION) FORMULATION TO PROTECT AGAINST COVID-19, THROUGH A PHASE I CLINICAL TRIAL.

Dates and value

Award date
Signed on Aug 21, 2020
Potential end of performance
Jun 29, 2024
Current value
$10,970,058Base and exercised options
Potential value (if all options are exercised)
$10,970,058

Obligations by fiscal year of action

  • FY2022: $2,717,614
  • FY2021: $4,015,904
  • FY2020: $4,236,540

Total across 3 fiscal years: $10,970,058

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Oct 26, 2023. View on USAspending · Recipient on SAM.gov

Recipient

LocationSEATTLE, WA
UEIZ33DCMWXZBK7
CAGE code7YDE0
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyHDT BIO CORP

Business types and certifications

For-profit organizationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Seattle, King County, Washington 98102-3788
Congressional district (place of performance)
WA-07As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost plus fixed feeU
Offers received
9

Solicitation and notices

Solicitation ID
HHS-NIH-NIAID-BAA2020-1
Solicitation date
Jan 3, 2020
Notices
More notices share this solicitation number; the newest are listed.

Contract details

Subcontracting plan
Plan not requiredB
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
Yes
Service Contract Act labor standards
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Aug 21, 2020Base obligation at award: $4,236,540
Latest action
Oct 26, 2023 — Supplemental agreement (within scope)Modification P00005
Latest substantive action
Oct 26, 2023 — Supplemental agreement (within scope)Modification P00005
Actions by type
  • Base award1
  • Supplemental agreement (within scope)3
  • Option exercised1
  • Other administrative action1
6 actions recorded, Aug 21, 2020 to Oct 26, 2023; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Critical functionsCT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Walsh-Healey Act (materials and supplies)
No
Construction wage rates (Davis-Bacon)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
6

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2020/2024-0885-000
  • 075-2021/2021-0885-000
  • 075-2022/2022-0885-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • L: Emergency P.L. 116-123
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
COVID-19 supplemental obligations
$4,236,540
COVID-19 supplemental outlays
$4,236,540